These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1381590)

  • 1. CSF monoamine metabolites in old age dementias.
    Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
    Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.
    Bråne G; Gottfries CG; Blennow K; Karlsson I; Lekman A; Parnetti L; Svennerholm L; Wallin A
    Alzheimer Dis Assoc Disord; 1989; 3(3):148-56. PubMed ID: 2477044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
    Parnetti L; Gottfries J; Karlsson I; Långström G; Gottfries CG; Svennerholm L
    Acta Psychiatr Scand; 1987 May; 75(5):542-8. PubMed ID: 2440238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.
    Blennow K; Wallin A; Gottfries CG; Lekman A; Karlsson I; Skoog I; Svennerholm L
    Neurobiol Aging; 1992; 13(1):107-13. PubMed ID: 1371850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia.
    Wallin A; Blennow K; Edman A; Månsson JE
    Int Psychogeriatr; 1996; 8(3):425-36. PubMed ID: 9116178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.
    Tohgi H; Ueno M; Abe T; Takahashi S; Nozaki Y
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):69-77. PubMed ID: 1540305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.
    Jolkkonen J; Helkala EL; Kutvonen R; Lehtinen M; Riekkinen PJ
    Psychoneuroendocrinology; 1989; 14(1-2):89-95. PubMed ID: 2471986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM; Sims NR; Bowen DM; Neary D; Palo J; Wikstrom J; Davison AN
    J Neurol Neurosurg Psychiatry; 1984 May; 47(5):481-4. PubMed ID: 6204017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.
    Nybäck H; Nyman H; Schalling D
    Acta Psychiatr Scand; 1987 Dec; 76(6):648-56. PubMed ID: 2450445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.
    Gibson CJ; Logue M; Growdon JH
    Arch Neurol; 1985 May; 42(5):489-92. PubMed ID: 2581531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of idebenone on monoamine metabolites in cerebrospinal fluid of patients with cerebrovascular dementia.
    Kawakami M; Itoh T
    Arch Gerontol Geriatr; 1989 May; 8(3):343-53. PubMed ID: 2475076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
    Kaye JA; May C; Daly E; Atack JR; Sweeney DJ; Luxenberg JS; Kay AD; Kaufman S; Milstien S; Friedland RP
    Neurology; 1988 Apr; 38(4):554-7. PubMed ID: 2451190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ; Stanley M; Neophytides A; de Leon MJ; Ferris SH; Gershon S
    Neurobiol Aging; 1981; 2(1):57-60. PubMed ID: 7266742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments.
    Freed DM; Corkin S; Growdon JH; Nissen MJ
    Neuropsychologia; 1988; 26(6):895-902. PubMed ID: 2461537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
    Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
    Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
    Sheline YI; Miller K; Bardgett ME; Csernansky JG
    Am J Geriatr Psychiatry; 1998; 6(2):155-61. PubMed ID: 9581211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementias, psychological tests, and neurotransmitters.
    Degrell I; Pék G; Nagy D; Nagy E; Hoyer S
    Arch Gerontol Geriatr; 1985 Dec; 4(4):365-71. PubMed ID: 2421656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.